848841-54-3 Usage
Uses
Used in Pharmaceutical Synthesis:
6-iodoquinazoline is used as an intermediate in the synthesis of various pharmaceutical compounds, primarily for the development of drugs targeting cancer and neurological disorders. The iodine atom in the compound facilitates chemical transformations that can enhance the therapeutic properties of the resulting pharmaceuticals.
Used in Organic Synthesis:
In the field of organic synthesis, 6-iodoquinazoline is utilized as a versatile building block. Its unique reactivity allows for the introduction of specific functional groups to the quinazoline ring, enabling the creation of a wide range of chemically diverse molecules with potential applications in various industries.
Used in Drug Discovery:
6-iodoquinazoline plays a significant role in drug discovery efforts due to its potential biological activity. Researchers use 6-iodoquinazoline to explore and develop new drugs with improved efficacy and selectivity, particularly for the treatment of cancer and neurological disorders.
Used in Medicinal Chemistry Research and Development:
6-iodoquinazoline is an important target for research and development in medicinal chemistry. Its unique properties and potential applications in pharmaceuticals make it a valuable subject for further exploration, with the aim of discovering new therapeutic agents and advancing the field of drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 848841-54-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,8,8,4 and 1 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 848841-54:
(8*8)+(7*4)+(6*8)+(5*8)+(4*4)+(3*1)+(2*5)+(1*4)=213
213 % 10 = 3
So 848841-54-3 is a valid CAS Registry Number.
848841-54-3Relevant academic research and scientific papers
1,4-DISUBSTITUTED ISOQUINILONE DERIVATIVES AS RAF-KINASE INHIBITORS USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES
-
Page/Page column 56, (2010/02/11)
This invention relates to compounds of formula (I) wherein the variable substituents are described herein. The compounds are useful for the treatment of conditions and diseases characterized by an aberrant MAP kinase signaling pathway, such as cancer.
4-amino-quinazolines
-
, (2008/06/13)
Quinazolines of the formula I, in which R, R1, R2, R3, R4 and Y have the meaning indicated in Patent claim 1, and their salts or solvates as glycoprotein IbIX antagonists.
